Fri, Sep 19, 2014, 9:26 AM EDT - U.S. Markets open in 4 mins.


% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

  • solarae solarae Apr 23, 2009 10:13 PM Flag

    VRTX Data at EASL Suggesting Telaprevir's Potential

    “Telaprevir is the only agent that has shown the possibility of achieving SVR rates in combination therapy approaching 70% in the treatment-naïve setting with a significantly shortened treatment duration when compared with current therapy, while our recently acquired polymerase compounds are showing strong early antiviral data, which may put us in a good position to shape new STAT-C combinations with telaprevir,” said Kurt Graves, Executive Vice President, Chief Commercial Officer and Head, Strategic Development of Vertex."

97.35+0.53(+0.54%)Sep 18 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Oracle Corporation
NYSEThu, Sep 18, 2014 4:04 PM EDT
Yahoo! Inc.
NasdaqGSThu, Sep 18, 2014 4:15 PM EDT